FAANGM Monthly July 22 – Strongest month of this year

11 Aug 2022
  • The FAANGM gained 13.4% in July, modestly better than the Nasdaq’s gain of 12.6%. The S&P 500 also gained 9.1% for the month. July saw its largest monthly gains for the year. FAANGM and Nasdaq remain down 20.7% YTD, while the S&P 500 is down 13.3%.
  • META and GOOGL were the laggards – down 2.0% and up 5.7% respectively, hurt by the pullback in economic sensitive advertising spend. AMZN and NFLX were the best performers, jumping 27.2% and 28.7% respectively, largely due to better-than-expected revenue/subscription numbers.
  • We remain OVERWEIGHT on FAANGM as we continue to believe that they will be long-term winners. Secular tailwinds remain intact for streaming, cloud, and digital advertising.

 

Review

Meta Platforms Inc (META US, BUY, TP US$221)

  • Increasing prices of VR headsets. Quest 2, the company’s VR headset product, is set for a US$100 increase from US$399 to US$499 for its 256GB model starting on 1 August. Meta said that these price increases were a result of increasing production and shipping costs.
  • FTC files suit to block the acquisition of Within. The Federal Trade Commission has filed a suit to prevent Meta from acquiring Within – creators of VR fitness app Supernatural, in a US$400mn deal. The FTC is claiming that the deal significantly lessens competition and accuses Meta of buying its way into the market – Meta already has its own VR fitness app, Oculus Move.

 

Comment: 2Q22 results were a mixed bag, with revenue in line with expectations, while earnings missed slightly. The increasing popularity of Reels continues to drive positive user growth for Meta, with ad impressions also increasing by 15% YoY. Guidance for 3Q22 was soft, citing continued weakness in advertising, and FX headwinds as the main reasons.

 

 

Apple Inc (AAPL US, BUY, TP US$194)

  • Apple Pay antitrust lawsuit. Apple faced another class-action complaint proposed by Affinity Credit Union that targeted Apple Pay, after European regulators found on a preliminary basis that Apple abused its dominant position with Apple Pay in the mobile wallets market. The complaint mainly circled around the fees Apple charges to credit and debit card issuers, which are absent in Google Pay and Samsung Pay. The union claimed those fees would not have been sustainable if Apple faced competition.
  • Scaling back hiring and spending. Apple is giving selected teams a lower-than-expected budget. The company will also not be increasing headcount in some groups in FY23. Despite the more cautious stance, Apple is still planning an aggressive product launch schedule in FY23 and a boost to the companywide compensation budget to cope with a tighter labor market

 

Comment: Apple announced a revenue beat during its 3Q22 earnings call, with iPhone and Services achieving record sales for the quarter, although Mac and iPad saw negative revenue growth. The iPhone active installed base reached a new all-time high, driven by strong growth in the number of switchers attracted during 3Q22 and sustained customer loyalty, with Services also benefiting from the growing installed base of the hardware segment. The decline in Mac and iPad was attributed to supply constraints as well as unfavorable FX. Apple expects revenue growth to accelerate in 4Q22, even with continued FX headwind and reduced supply chain constraints.

 

Amazon Inc (AMZN US, BUY, TP US$133)

  • Prime Day 2022 was the biggest Prime Day event in Amazon’s history. More than 300 million items were sold during the two-day event, up from approximately 250 million in FY21. This performance came as a pleasant surprise given the current high inflationary environment where consumers were expected to cut back on their spending.
  • Deploying Rivian electric delivery vans. Amazon began rolling out the electric delivery vans that it developed in collaboration with Rivian Automotive. The company said it will use the electric vehicles to make deliveries in a handful of cities, including Chicago, Dallas, Phoenix, San Diego, Seattle and St. Louis. The move marks a significant step in Amazon’s push to achieve net-zero carbon emissions across its operation by 2040.
  • Acquisition of 1Life Healthcare. Amazon acquired 1Life Healthcare, One Medical’s parent company, in an all-cash deal of roughly US$3.9 billion. The acquisition, which followed the purchase of the online pharmacy company Pillpack in 2018, is part of the company’s effort to deepen its presence in the healthcare sector.

 

Comment: Amazon announced mixed performance in its 2Q22 results call. Revenue beat top-end guidance and analyst consensus, resulting in positive operating income that was solely attributed to AWS. However, the company recorded a net loss for the quarter, mainly due to the writeoff on equity investment in Rivian Automotive. The success of the One Meddical acquisition is yet to be seen as it will require beating experienced entrenched rivals and competing for physicians for Amazon to disrupt the healthcare sector. Amazon also provided positive revenue guidance mainly as Prime Day happened in 3Q22, despite the expected persisting FX headwind.

About the author

Jonathan Woo
Research Analyst
PSR

Jonathan covers the US technology sector focusing on internet companies. Formerly a national and professional athlete, he graduated from the University of Oregon with a Bachelor’s Degree in Social Sciences.

Latest Reports

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com